Moon phase today: What the Moon will look like on April 2

As of Thursday, April 2, the Moon phase is North America is Waning Gibbous, according to NASA's Daily Moon Guide.
Fierce Biotech

Immunovant’s FcRn inhibitor flunks phase 3 eye disease trials, validating biotech’s waning interest

Immunovant’s first-generation FcRn inhibitor flunked a pair of phase 3 eye disease trials, appearing to end the last hopes of ...
Managed Healthcare Executive

Phase 3 trial program begins for investigational sleep medication, alixorexton

Alkermes announced today the initiation of the Brilliance Studies, a phase 3 program that will test the safety and efficacy ...
Medscape

Phase 2b Findings Support Novel Agent to Treat Alopecia Areata

A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe ...

Soligenix (NASDAQ: SNGX) Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including ...

AI As Co-Founder: Building Your First Agent Team (Phase Two)

In Phase One of this series, I focused on how entrepreneurs and founders can use AI as a thought partner to challenge assumptions, sharpen market understanding and validate problems before they even ...